Lind Global Fund II LP 13D and 13G filings for Bone Biologics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-06-26 4:50 pm Purchase |
2023-06-16 | 13G | Bone Biologics Corporation BBLG |
Lind Global Fund II LP | 25,381 6.500% |
25,381![]() (New Position) |
Filing |